Letters: End the false economy of generic prescribing

The warning of adverse events linked to the use of generic drug alendronate in your article 'Side-effects of NICE-backed drug "wipe out cost savings"' (GP, 19 September) comes from a consultant physician.

It seems that NICE is not nice nor a patient-friendly regulatory body any more.

The UK is adapting policy to save money at the expense of patients' misery. Surely NICE can find a sensible alternative to this ridiculous false economy.

GPs are all too well aware of the adverse effects patients suffer from not only generic alendronate, but also many other cheap products pushed into the system. The incentive scheme is a failure and it is about time we reverted to prescribing branded, clean and well-tested pharmaceutical products ethically.

Dr Hari Nawal, Bedford.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

BMA mourns 'dark death toll' as UK passes 100,000 COVID-19 deaths

BMA mourns 'dark death toll' as UK passes 100,000 COVID-19 deaths

More than 100,000 people have now died from COVID-19 in the UK, five times the death...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

Viewpoint: End-of-life care in care homes goes well beyond COVID-19

Viewpoint: End-of-life care in care homes goes well beyond COVID-19

Best practice standards for GPs and teams caring for older people in care homes -...

Locum GPs left behind in patchy COVID-19 vaccine rollout

Locum GPs left behind in patchy COVID-19 vaccine rollout

COVID-19 vaccination for locum GPs has trailed behind the rollout to other doctors,...

Four in five over-80s have had first COVID-19 jab despite weekend slump in vaccinations

Four in five over-80s have had first COVID-19 jab despite weekend slump in vaccinations

Almost 80% of people aged over 80 in the UK have have had at least one dose of COVID-19...

Fitness to practise and revalidation to continue despite pandemic, GMC confirms

Fitness to practise and revalidation to continue despite pandemic, GMC confirms

Revalidation and ongoing fitness to practise cases will continue despite huge pressure...